about
Pattern of referral of noncancer patients to palliative care in the eastern province of saudi arabia.Hospitalization pattern in a hospital-based palliative care program: an example from Saudi Arabia.Predictive impact of electrolyte abnormalities on the admission outcome and survival of palliative care cancer referrals.The use of opioids at the end-of-life and the survival of Egyptian palliative care patients with advanced cancer.Timing and Outcome of Referral to the First Stand-Alone Palliative Care Center in the Eastern Mediterranean Region, the Palliative Care Center of Kuwait.Opioid needs of patients with advanced cancer and the morphine dose-limiting law in Egypt.Where do Egyptian palliative care patients with cancer die?For a peaceful cancer death in Egypt: palliative care is not...The fear of using tramadol for pain control (tramadolophobia) among Egyptian patients with cancer.The Use of the Chuang's Prognostic Scale to Predict the Survival of Metastatic Colorectal Cancer Patients Receiving Palliative Systemic Anticancer Therapy.Naproxen test for neoplastic fever may reduce suffering.Emergency Department Visits at the End of Life of Patients With Terminal Cancer: Pattern, Causes, and Avoidability.A shortage of oral morphine in Egypt.Regulations governing morphine prescription in Egypt: an urgent need for modification.Symptom burden in hospitalized patients with cancer in kuwait and the need for palliative care.Palliative care consultation versus palliative care unit: which is associated with shorter terminal hospitalization length of stay among patients with cancer?Prediction of in-hospital mortality of patients with advanced cancer using the Chuang Prognostic Score.Pattern of cancer deaths in a saudi tertiary care hospital.High Symptom Burden Among Patients With Newly Diagnosed Incurable Cancer in a Developing Country.Cancer diagnosis disclosure preferences of family caregivers of cancer patients in Egypt.Heart rate variability measurement: is there a role in predicting the admission outcome of palliative cancer patients?The Relation Between the Timing of Palliative Care and the Frequency and Timing of Do-Not-Resuscitate Orders Among Cancer Deaths in a Tertiary Care Hospital.Palliative care: an unexplored aspect of schistosomiasis neglect?Voluntary reporting to assess symptom burden among Yemeni cancer patients: common symptoms are frequently missed.White Paper for Global Palliative Care Advocacy: Recommendations from a PAL-LIFE Expert Advisory Group of the Pontifical Academy for Life, Vatican CityPsychiatric and functional neuroimaging abnormalities in chronic hepatitis C virus patients: Is vasculitis a contributing factor?The place of death of patients with cancer in Kuwait: Table 1Prevalence of Methicillin-Resistant Staphylococcus aureus Colonization and Infection in Hospitalized Palliative Care Patients With CancerRepresentation of Expatriates Among Cancer Patients in Kuwait and the Need for Culturally-Competent CareThe Palliative Prognostic Index for the Prediction of Survival and In-Hospital Mortality of Patients with Advanced Cancer in KuwaitTransdermal fentanyl to parenteral morphine route switch and drug rotation in refractory cancer cachexiaPreferred Place of Death for Patients With Incurable Cancer and Their Family Caregivers in Egypt
P50
Q35748868-B6CF285A-2F22-4A90-AB76-885188C790B4Q37306325-549356F4-1479-4236-9E4E-6051370212E3Q37389512-AE16451C-1EC1-4F0B-B147-8390D5939A3BQ38405145-80F4F7E3-6814-49C5-A450-D3EBD6EDD66BQ38695962-026E088C-9475-43D2-88A2-D0F034106A78Q38870911-087263AC-BD75-42A3-9656-8AB981E87AEBQ38870918-F962C35E-CB9E-4015-BB21-45C4A4488733Q38870921-797E76F9-5447-47F1-939C-3CC52DCEEFECQ39199869-596FAF9A-27AD-4BB6-8B63-5415312667EFQ39200624-8ABB8CFD-11D1-489D-A6FF-D491D014B82FQ40335278-856E30BD-8F2C-40C5-8088-9530789295FCQ41067558-E4D57B1B-FA58-493D-88BD-73BF2B74BD03Q43093045-6D3F3FC3-DAAC-46C0-9622-C14BAF9B8409Q43255658-527DCB65-013A-40A2-B5C0-DD4096AEAE21Q43441903-A833D1D7-311B-4CD4-ADFC-4BFD3F10CFCCQ43726455-B7F2E3EA-D67E-4495-BF3C-7F4BAFBDF94DQ44299669-C3280235-FADD-49BF-ACFC-018549F7F48DQ45845110-A1962888-1013-48F2-A747-F1C0DD589C08Q46197299-5126A3D9-58FB-4050-80EA-63C29D99D3D6Q46284162-1A87DBE7-E41B-4310-BF54-EE06077614FCQ46332986-69B2F094-C011-46D5-B75A-6B3E94D91D04Q46912347-03569693-A15B-44A8-BD3C-3EE574DCC2B0Q48687574-D75D2F9D-C5B4-4BE0-A622-5C325B82B1D2Q53766704-64715082-7E50-4C3F-9CF4-98DA7C0C0F71Q56909093-65384BA7-42D4-496E-AFB8-8AD11239A61FQ58876502-92DA937F-0A02-44B3-A0CD-444FE80EBCF0Q58876524-DEBEBED7-8E8D-412E-AC21-557B46572FDDQ58876527-064F9B45-61E5-4E99-8C80-816E06BBE6ACQ58876534-662C0D30-DC9F-4138-8549-9B2796DD22BEQ58876536-9B9A4C6A-8DED-430F-BE4B-0E59EEA819FDQ93160658-1CA17733-9C28-4A8C-BB8C-3EB34E84BABDQ93376650-2FA1A4F9-7B51-49C2-865D-858493CD67F7
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Samy A Alsirafy
@es
Samy A. Alsirafy
@en
Samy A. Alsirafy
@nl
Samy A. Alsirafy
@sl
type
label
Samy A Alsirafy
@es
Samy A. Alsirafy
@en
Samy A. Alsirafy
@nl
Samy A. Alsirafy
@sl
prefLabel
Samy A Alsirafy
@es
Samy A. Alsirafy
@en
Samy A. Alsirafy
@nl
Samy A. Alsirafy
@sl
P106
P1153
22936595300
P21
P31
P496
0000-0003-4282-6671
P569
2000-01-01T00:00:00Z